Personalized Cancer Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!
LONDON, GREATER LONDON, UNITED KINGDOM, November 22, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!
The personalized cancer treatment market has seen unprecedented growth in recent years, growing from $163.95 billion in 2023 to $181.55 billion in 2024 at a compound annual growth rate CAGR of 10.7%. This impressive surge can be linked to significant advancements in genomics and molecular biology, an increasing prevalence of cancer, growing adoption of personalized medicine, heightened awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies.
What Magnitude of Growth Do We Expect in the Personalized Cancer Treatment Market?
Looking ahead, the outlook for the personalized cancer treatment market continues to be promising. Predicted to grow to $237.92 billion in 2028, at a CAGR of 10.8%, the rapid growth in the forecast period is anticipated to be fueled by the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. The forecast period will also see major trends such as rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models.
Sample the detailed report here: https://www.thebusinessresearchcompany.com/sample.aspx?id=19135&type=smp
What's Driving Growth In The Personalized Cancer Treatment Market?
The increasing prevalence of cancer worldwide is projected to be a major catalyst for the growth of the personalized cancer treatment market. The higher incidence of cancer can be largely attributed to increasing life expectancy, which results in more people reaching an age where cancer is more common, along with growing exposure to risk factors such as tobacco, alcohol, and obesity. Personalized cancer treatments, which provide targeted and effective therapies to manage diverse cancer types and stages, are being increasingly sought after. This growing demand is sparking increased investment and innovation in precision medicine aimed at improving patient outcomes through customized treatment plans. As an example, in February 2024, data from the World Health Organization pointed to a steep anticipated increase in global cancer cases, with an expected total of over 35 million by 2050 compared to 20 million in 2022. This increasing cancer prevalence is likely to be a key driver for the personalized cancer treatment market.
Reserve a copy of the full report today: https://www.thebusinessresearchcompany.com/report/personalized-cancer-treatment-global-market-report
What Are Noteworthy Innovations and Emerging Trends In The Personalized Cancer Treatment Market?
Some of the leading companies in the personalized cancer treatment market are making significant strides in innovative solutions, such as artificial intelligence AI-enabled multimodal immune profile algorithmic tests. Leveraging multiple data types, including genomic, transcriptomic, and clinical biomarkers, these tests assess a patient's immune profile and predict their response to immunotherapy – thereby enhancing patient stratification and treatment selection in oncology. For example, in July 2024, US health technology company Tempus AI, Inc. launched its first solution in the immunotherapy diagnostics space – an AI-enabled multimodal immune profile algorithmic test dubbed IPS.
How Is the Market Segmented?
The personalized cancer treatment market is delineated into several segments:
1 By Treatment Type: Targeted Therapy, Immunotherapy, Hormone Therapy, Chemotherapy, Radiation Therapy, Other Treatment Type
2 By Diagnostic Techniques: Genomic Sequencing, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization, Biomarker Testing, Other Diagnostic Techniques
3 By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Other Cancer Types
4 By End-Users: Hospitals And Clinics, Research Institutes, Other End Users
Browse More Related Reports:
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Small Cell Lung Cancer Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report
Blood Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
